Novel truncating and missense mutations of the KCC3 gene associated with Andermann syndrome.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 16606917)

Published in Neurology on April 11, 2006

Authors

G Uyanik1, N Elcioglu, J Penzien, C Gross, Y Yilmaz, A Olmez, E Demir, D Wahl, K Scheglmann, B Winner, U Bogdahn, H Topaloglu, U Hehr, J Winkler

Author Affiliations

1: Department of Neurology, University of Regensburg, Germany.

Articles citing this

Physiology of SLC12 transporters: lessons from inherited human genetic mutations and genetically engineered mouse knockouts. Am J Physiol Cell Physiol (2013) 1.01

Mutations affecting GABAergic signaling in seizures and epilepsy. Pflugers Arch (2010) 0.99

Epigenetic approaches to psychiatric disorders. Dialogues Clin Neurosci (2010) 0.99

Transit defect of potassium-chloride Co-transporter 3 is a major pathogenic mechanism in hereditary motor and sensory neuropathy with agenesis of the corpus callosum. J Biol Chem (2011) 0.85

N-terminal serine dephosphorylation is required for KCC3 cotransporter full activation by cell swelling. J Biol Chem (2013) 0.83

Deletion of KCC3 in parvalbumin neurons leads to locomotor deficit in a conditional mouse model of peripheral neuropathy associated with agenesis of the corpus callosum. Behav Brain Res (2014) 0.82

K-Cl cotransporters, cell volume homeostasis, and neurological disease. Trends Mol Med (2015) 0.81

A deletion mutation in Slc12a6 is associated with neuromuscular disease in gaxp mice. Genomics (2008) 0.77

Regulated phosphorylation of the K-Cl cotransporter KCC3 is a molecular switch of intracellular potassium content and cell volume homeostasis. Front Cell Neurosci (2015) 0.76

A patient with multisystem dysfunction carries a truncation mutation in human SLC12A2, the gene encoding the Na-K-2Cl cotransporter, NKCC1. Cold Spring Harb Mol Case Stud (2016) 0.75

KCC3 axonopathy: neuropathological features in the central and peripheral nervous system. Mod Pathol (2016) 0.75

Articles by these authors

Accessing genetic information with high-density DNA arrays. Science (1996) 13.89

New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet (1999) 5.92

Invertase signal and mature sequence substitutions that delay intercompartmental transport of active enzyme. J Cell Biol (1985) 4.24

Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J Neurosci (1997) 3.61

The molecular architecture of focal adhesions. Annu Rev Cell Dev Biol (1995) 3.41

Proliferation and differentiation of progenitor cells throughout the intact adult rat spinal cord. J Neurosci (2000) 3.40

The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet (2000) 3.35

Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell (2001) 3.29

Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet (1995) 3.05

Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J (1995) 2.67

Mutations in the homeodomain of the human SIX3 gene cause holoprosencephaly. Nat Genet (1999) 2.57

Note on the nitrogen content of certain proteins. Biochem J (1932) 2.54

Analysis of neurogenesis and programmed cell death reveals a self-renewing capacity in the adult rat brain. Neurosci Lett (2000) 2.22

Cloning and characterization of a novel human class I histone deacetylase that functions as a transcription repressor. J Biol Chem (2000) 2.19

Identification of a contact site for different transcription activators in region 4 of the Escherichia coli RNA polymerase sigma70 subunit. J Mol Biol (1998) 2.19

Striatal grey matter increase in patients suffering from fibromyalgia--a voxel-based morphometry study. Pain (2007) 2.18

Indicators of lifetime endogenous estrogen exposure and risk of venous thromboembolism. J Thromb Haemost (2006) 2.17

Determination of intrinsic transcription termination efficiency by RNA polymerase elongation rate. Science (1994) 2.14

Intravenous immunoglobulin treatment in children with Guillain-Barré syndrome. Eur J Paediatr Neurol (1997) 2.12

Long-term outcome after thrombolysis in telemedical stroke care. Neurology (2007) 2.12

[Number of patients with chronic dyspnea in three German specialist practices]. Pneumologie (2012) 2.08

Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation. Am J Transplant (2014) 2.02

Optic neuritis and myelitis after booster tetanus toxoid vaccination. Lancet (1992) 2.02

Combination therapy with bosentan and sildenafil in idiopathic pulmonary arterial hypertension. Eur Respir J (2004) 2.02

Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther (2013) 2.00

Renal impairment and coronary collaterals in patients with acute coronary syndrome. Herz (2013) 2.00

Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease. Neurology (2001) 1.97

Successful treatment of anti-N-methyl-D-aspartate receptor encephalitis presenting with catatonia. Arch Dis Child (2009) 1.84

Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients. Pain (2006) 1.83

Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy. Neurology (2002) 1.82

Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology (1995) 1.77

Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet (1997) 1.76

Rapid micromethod for the purification of Escherichia coli ribonucleic acid polymerase and the preparation of bacterial extracts active in ribonucleic acid synthesis. J Bacteriol (1976) 1.76

The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol Disord Drug Targets (2006) 1.74

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol (2000) 1.73

Gray matter decrease in patients with chronic tension type headache. Neurology (2005) 1.71

Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67

Acute and long-term effects of subthalamic nucleus stimulation in Parkinson's disease. Stereotact Funct Neurosurg (1994) 1.66

Evaluation of cerebral vasospasm after early surgical and endovascular treatment of ruptured intracranial aneurysms. Neurosurgery (1998) 1.63

Magnetic resonance imaging characteristics of benign macrocephaly in children. J Child Neurol (1999) 1.60

Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet (2000) 1.58

Orexin receptor antagonism, a new sleep-promoting paradigm: an ascending single-dose study with almorexant. Clin Pharmacol Ther (2010) 1.57

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group. Ann Intern Med (2000) 1.57

Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56

Mutations in SEPN1 cause congenital muscular dystrophy with spinal rigidity and restrictive respiratory syndrome. Nat Genet (2001) 1.56

Increased QT dispersion in breath-holding spells. Acta Paediatr (2004) 1.54

The Spastic Paraplegia Rating Scale (SPRS): a reliable and valid measure of disease severity. Neurology (2006) 1.54

Intraparenchymal infusions of 192 IgG-saporin: development of a method for selective and discrete lesioning of cholinergic basal forebrain nuclei. J Neurosci Methods (1999) 1.52

A 14-mer Hsp70 peptide stimulates natural killer (NK) cell activity. Cell Stress Chaperones (2001) 1.52

Factors influencing breath condensate volume. Pneumologie (2001) 1.51

[Diagnosis and therapy of carpal tunnel syndrome--guideline of the German Societies of Handsurgery, Neurosurgery, Neurology, Orthopaedics, Clinical Neurophysiology and Functional Imaging, Plastic, Reconstructive and Aesthetic Surgery, and Surgery for Traumatology]. Handchir Mikrochir Plast Chir (2007) 1.51

Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur J Neurosci (1993) 1.51

Prolonged survival with valproic acid use in the EORTC/NCIC temozolomide trial for glioblastoma. Neurology (2011) 1.48

Mutation affecting thermostability of sigma subunit of Escherichia coli RNA polymerase lies near the dnaG locus at about 66 min on the E. coli genetic map. Proc Natl Acad Sci U S A (1978) 1.48

Location and type of mutation in the LIS1 gene do not predict phenotypic severity. Neurology (2007) 1.45

Long-term outcome with intravenous iloprost in pulmonary arterial hypertension. Eur Respir J (2009) 1.44

Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis. Am J Clin Pathol (1998) 1.43

Gastric versus duodenal feeding and gastric tonometric measurements. Crit Care Med (1998) 1.43

Functional imaging in PNH caused by a new FilaminA mutation. Neurology (2004) 1.43

The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res (1997) 1.43

Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis. Acta Neurol Scand (2011) 1.42

Detection and volume estimation of embolic air in the middle cerebral artery using transcranial Doppler sonography. Stroke (1994) 1.41

Defective serum opsonization activity in children aged 6-48 months having acute purulent otitis media. Turk J Pediatr (1998) 1.40

A homozygous nonsense mutation in the fukutin gene causes a Walker-Warburg syndrome phenotype. J Med Genet (2003) 1.40

[Effects of the stimulation of the subthalamic nucleus in Parkinson disease]. Rev Neurol (Paris) (1993) 1.39

In vivo cartilage contact deformation in the healthy human tibiofemoral joint. Rheumatology (Oxford) (2008) 1.39

Increased nuchal translucency and pathological ductus venosus flow: two cases of TRAP sequence with different outcomes. Ultrasound Obstet Gynecol (2002) 1.39

Aortic valve replacement with the pulmonary autograft--experience of 23 cases. Thorac Cardiovasc Surg (1992) 1.39

High prevalence of vitamin D deficiency, secondary hyperparathyroidism and generalized bone pain in Turkish immigrants in Germany: identification of risk factors. Osteoporos Int (2006) 1.39

Cubital tunnel syndrome - a review and management guidelines. Cent Eur Neurosurg (2011) 1.39

Decrease of thalamic gray matter following limb amputation. Neuroimage (2006) 1.38

[Correlation of TEI Index and invasive parameters of rightheart function in PAH]. Pneumologie (2004) 1.38

ARX mutations in X-linked lissencephaly with abnormal genitalia. Neurology (2003) 1.36

Adult neurogenesis and neurite outgrowth are impaired in LRRK2 G2019S mice. Neurobiol Dis (2010) 1.35

Cloning of a novel malignant melanoma-derived growth-regulatory protein, MIA. Cancer Res (1994) 1.32

Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet (1999) 1.31

Cell cycle regulation of cdc25C transcription is mediated by the periodic repression of the glutamine-rich activators NF-Y and Sp1. Nucleic Acids Res (1995) 1.31

Mutations in the rpoH (htpR) gene of Escherichia coli K-12 phenotypically suppress a temperature-sensitive mutant defective in the sigma 70 subunit of RNA polymerase. J Bacteriol (1985) 1.31

PATIKAweb: a Web interface for analyzing biological pathways through advanced querying and visualization. Bioinformatics (2005) 1.31

Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function. J Med Genet (2009) 1.31

Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass. J Thorac Cardiovasc Surg (1991) 1.30

Cloning and characterization of the human and rat islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP) genes. J Biol Chem (2001) 1.28

Ageing abolishes the effects of fluoxetine on neurogenesis. Mol Psychiatry (2009) 1.28

Confirming genes influencing risk to cleft lip with/without cleft palate in a case-parent trio study. Hum Genet (2013) 1.28

Donor Y chromosome in renal carcinoma cells of a female BMT recipient: visualization of putative BMT-tumor hybrids by FISH. Bone Marrow Transplant (2005) 1.27

Frequency and phenotype of SPG11 and SPG15 in complicated hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry (2009) 1.26

The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J Urol (1996) 1.25

Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7  TeV. Phys Rev Lett (2012) 1.23

Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci. Am J Hum Genet (2001) 1.23

Subtle grey matter changes between migraine patients and healthy controls. Cephalalgia (2007) 1.22